IRIS UniCatt

Laterza, Lucrezia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.741
AS - Asia 2.916
EU - Europa 2.763
SA - Sud America 639
AF - Africa 79
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.158
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.599
SG - Singapore 1.337
DE - Germania 623
CN - Cina 622
IT - Italia 599
BR - Brasile 516
SE - Svezia 354
FR - Francia 273
VN - Vietnam 271
PL - Polonia 204
GB - Regno Unito 150
FI - Finlandia 121
IN - India 111
UA - Ucraina 109
BD - Bangladesh 97
IE - Irlanda 94
ID - Indonesia 90
JP - Giappone 81
HK - Hong Kong 73
CA - Canada 67
AR - Argentina 51
RU - Federazione Russa 47
KR - Corea 42
TR - Turchia 41
NL - Olanda 39
MX - Messico 37
IQ - Iraq 33
ES - Italia 29
BE - Belgio 24
ZA - Sudafrica 23
AT - Austria 20
AU - Australia 14
CL - Cile 13
EC - Ecuador 13
IR - Iran 13
JM - Giamaica 13
SA - Arabia Saudita 13
VE - Venezuela 13
CO - Colombia 12
PK - Pakistan 12
CZ - Repubblica Ceca 11
RO - Romania 11
PH - Filippine 10
LT - Lituania 9
JO - Giordania 8
PY - Paraguay 8
UZ - Uzbekistan 8
BB - Barbados 7
CI - Costa d'Avorio 7
DZ - Algeria 7
EG - Egitto 7
KZ - Kazakistan 7
MA - Marocco 7
TN - Tunisia 7
AZ - Azerbaigian 6
CH - Svizzera 6
KE - Kenya 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
HU - Ungheria 5
MY - Malesia 5
BG - Bulgaria 4
BO - Bolivia 4
ET - Etiopia 4
HR - Croazia 4
IL - Israele 4
LV - Lettonia 4
OM - Oman 4
PE - Perù 4
UY - Uruguay 4
AL - Albania 3
CD - Congo 3
DO - Repubblica Dominicana 3
EU - Europa 3
GT - Guatemala 3
LB - Libano 3
NP - Nepal 3
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
KG - Kirghizistan 2
KW - Kuwait 2
MD - Moldavia 2
MM - Myanmar 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
YE - Yemen 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
Totale 10.138
Salva come PNG Salva come JPEG
Città #
Singapore 772
San Jose 420
Ashburn 401
Chandler 336
Warsaw 173
Los Angeles 128
New York 126
Beijing 123
Rome 123
Hefei 100
Ho Chi Minh City 92
Dublin 91
Lauterbourg 79
Milan 78
Tokyo 74
Dallas 73
Frankfurt am Main 73
Hanoi 73
Jakarta 73
Jacksonville 71
Munich 71
Ann Arbor 68
Council Bluffs 66
Hong Kong 66
Helsinki 64
São Paulo 63
San Mateo 62
The Dalles 60
Cattolica 54
Boardman 47
Boston 47
Wilmington 42
Seoul 39
Nanjing 37
Buffalo 34
Houston 34
Santa Clara 31
Woodbridge 30
Kent 29
Moscow 28
Dearborn 27
St Louis 27
Chicago 26
Fairfield 25
Marseille 25
North Bergen 25
Nuremberg 24
Nürnberg 24
Orem 24
Brooklyn 23
Hyderabad 22
Lawrence 22
Seattle 22
Atlanta 21
London 21
Brussels 20
Denver 20
Paris 20
Montreal 19
Turku 19
Chennai 18
Princeton 18
Stockholm 18
Toronto 18
Izmir 17
Tianjin 17
Haiphong 16
Lappeenranta 16
Poplar 16
Shanghai 16
Baghdad 15
Düsseldorf 15
Kraków 15
Lancaster 15
Manchester 15
Phoenix 15
Da Nang 14
Johannesburg 14
Redwood City 14
San Francisco 14
Amsterdam 13
Bremen 13
Mexico City 13
Naples 13
Belo Horizonte 12
Rio de Janeiro 12
Hangzhou 11
Monza 11
Mountain View 11
Mumbai 11
Porto Alegre 11
Shenyang 11
Fremont 10
Guangzhou 10
Macerata 10
Roubaix 10
Salvador 10
Vienna 10
Hebei 9
Kingston 9
Totale 5.443
Salva come PNG Salva come JPEG
Nome #
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 373
Irritable bowel syndrome and nickel allergy: What is the role of the low nickel diet? 235
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases 207
13C-octanoic acid breath test to study gastric emptying time 186
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 183
Clinical value of alarm features for colorectal cancer: A meta-analysis 181
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 172
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 168
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 159
Erratum to: Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study (Scientific Reports, (2018), 8, 1, (12624), 10.1038/s41598-018-29311-y) 157
Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study 156
Origin of celiac disease: How old are predisposing haplotypes? 154
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 154
Diet-Induced Alterations in Gut Microbiota Composition and Function 154
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 153
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 151
The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights 151
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 151
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 151
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 150
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 150
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 149
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 144
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 143
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 142
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 139
Addressing Nutritional Knowledge Gaps in Inflammatory Bowel Disease: A Scoping Review 130
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 129
Extracellular Vesicles: Novel Potential Therapeutic Agents in Inflammatory Bowel Diseases 128
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study 127
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 127
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 126
Fibrostenosing Crohn's Disease: Pathogenetic Mechanisms and New Therapeutic Horizons 126
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease 126
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 125
Gastrointestinal motility disorder assessment in systemic sclerosis 125
Pancreatic function assessment 125
Gut and reproductive tract microbiota adaptation during pregnancy: New insights for pregnancy-related complications and therapy 122
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 121
Popular diets and nutritional assessment in the management of irritable bowel syndrome in inflammatory bowel disease: an overview of current evidence 121
Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment 120
Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients 119
Review Article: Green Management of IBD—New Paradigms for an Eco-Friendly Approach 119
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 119
Crohn's Disease: Radiological Answers to Clinical Questions and Review of the Literature 118
Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together 116
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 116
Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative Colitis 115
Radiomics could predict surgery at 10 years in Crohn's disease 114
Gastrointestinal motility disorder assessment in systemic sclerosis 113
Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome 112
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy 111
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 109
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 107
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study 105
Clinical value of alarm features for colorectal cancer: A meta-analysis 103
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE 101
PET in inflammatory bowel diseases: a new FAPI era? 100
Clinical, Radiological, and Surgical Risk Factors for Endoscopic Anastomotic Recurrence Following Surgery in Crohn's Disease 97
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 97
Gut and reproductive tract microbiota adaptation during pregnancy: New insights for pregnancy-related complications and therapy 94
Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study 94
Vascular complications in hospitalized patients with inflammatory bowel disease and acute gastroenteritis and colitis: A propensity score-matched study 89
The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights 89
Bariatric procedures and microbiota: patient selection and outcome prediction 89
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER Study 85
SECRETOME MODULATION OF CACO2 CELL LINE INDUCED BY A MULTI-STRAIN PROBIOTIC 85
Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn’s disease treated with ustekinumab 83
Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients 81
How to identify patients who are less likely to have metachronous neoplasms after a colon cancer: A predictive model 80
Clinical Trial IBD Unit: The Role of the Study Nurse in Conduction of Trials and Patients' Care 79
Cancer Risk in IBD Patients Treated with JAK Inhibitors: Reassuring Evidence from Trials and Real-World Data 79
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis 75
Systematic review with meta-analysis: the appropriateness of colonoscopy increases the probability of relevant findings and cancer while reducing unnecessary exams 74
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 72
Risk factors for gastric cancer: is it time to discard PPIs? 71
Higher adenoma recurrence rate after left- versus right-sided colectomy for colon cancer 69
The diagnostic yield of colonoscopy in hospitalized patients. An observational multicenter prospective study 69
Systematic review with meta-analysis: the appropriateness of colonoscopy increases the probability of relevant findings and cancer while reducing unnecessary exams 68
Onset of ulcerative colitis after thyrotoxicosis: a case report and review of the literature 66
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis 66
The diagnostic yield of colonoscopy in hospitalized patients. An observational multicenter prospective study 58
European Consensus on Malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN: Part 2: Screening, Special Populations, Nutritional Goals, Supportive Care, Primary Care Perspective 54
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 40
European Consensus on Malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN. Part 1: Definitions, Clinical Phenotypes, and Diagnostic Testing for Malabsorption 36
Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial 22
OCTN1 variants shape innate immunity and predict individual response to anti-TNFα in ulcerative colitis patients: An exploratory study 16
Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology 15
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study 6
Inflammatory bowel disease (IBD) is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activity 4
Validation of the Ontario Protocol Assessment Level (OPAL) Tool for Assessing Clinical Trial Complexity and Supporting Workforce Planning in the Italian Clinical Research Context 3
Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn's Disease: A Prospective Study 3
Federated learning in inflammatory bowel disease: The future of privacy-preserving Artificial Intelligence 1
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study 1
Navigating the Intersection: Sarcopenia and Sarcopenic Obesity in Inflammatory Bowel Disease 1
Timing of biologic prophylaxis and postoperative recurrence in Crohn's disease: A real-life cohort study using propensity score weighting 1
Totale 10.300
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.625
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.625
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022364 15 25 5 14 22 16 6 71 14 51 56 69
2022/2023930 108 126 79 136 58 101 55 79 93 36 40 19
2023/2024728 25 125 51 46 42 108 50 19 46 34 82 100
2024/20251.843 27 42 147 52 139 63 116 78 181 238 422 338
2025/20264.733 615 195 330 578 737 253 687 235 347 345 180 231
2026/2027194 194 0 0 0 0 0 0 0 0 0 0 0
Totale 10.300